Literature DB >> 19180311

Rapid response to a case of mumps: implications for preventing transmission at a medical research facility.

Gabriela Salmón-Mulanovich1, Gregory Utz, Andrés G Lescano, David E Bentzel, David L Blazes.   

Abstract

OBJECTIVE: To prevent transmission among the staff and potentially among the non-human primate (NHP) colony at the U.S. Naval Medical Research Center Detachment in Peru, where an active case of mumps was discovered in a senior laboratory technician in Sep 03, 2007.
MATERIAL AND METHODS: Subjects at the research facility were interviewed and potentially susceptible contacts were tested for mumps IgG.
RESULTS: In total, 81 out of 106 staff members (76%) had close contact with the case. Only 6/81 (7%) had MMR, 33 (41%) reported having had mumps, and 8 of 45 (18%) of the potentially susceptible individuals did not have immunity (IgG > 20.0). All the susceptible, exposed individuals received MMR vaccine. There were no secondary cases and access to the NHP colony was restricted. DISCUSSION: Immediate and thorough investigation and occupational health response were imperative in preventing secondary cases of mumps among humans and NHP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19180311      PMCID: PMC4080888     

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  12 in total

1.  Misled and confused? Telling the public about MMR vaccine safety. Measles, mumps, and rubella.

Authors:  C J Clements; S Ratzan
Journal:  J Med Ethics       Date:  2003-02       Impact factor: 2.903

2.  The impact of a school entry law on adolescent immunization rates.

Authors:  Thad R Wilson; Daniel B Fishbein; Peggy A Ellis; Stanley A Edlavitch
Journal:  J Adolesc Health       Date:  2005-12       Impact factor: 5.012

3.  Mumps epidemic--Iowa, 2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2006-04-07       Impact factor: 17.586

4.  Mumps outbreak at a summer camp--New York, 2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2006-02-24       Impact factor: 17.586

5.  Response to experimental infection with mumps virus in rhesus monkeys.

Authors:  T D Flanagan; J A Andrada; A L Barron; E Witebsky
Journal:  Infect Immun       Date:  1971-05       Impact factor: 3.441

6.  [Mumps epidemic in the health area of Toledo with immunization intervention. Estimation of vaccine effectiveness].

Authors:  K Fernández de la Hoz Zeitler; C García Colmenero; M J Puchades Belenguer; C Verde López; J L Carpintero Redondo; F Alcázar Casanova
Journal:  Med Clin (Barc)       Date:  1997-02-08       Impact factor: 1.725

7.  Pathogenicity of mumps virus in the marmoset.

Authors:  Shizuko Saika; Minoru Kidokoro; Tokitada Ohkawa; Atuko Aoki; Kazuyoshi Suzuki
Journal:  J Med Virol       Date:  2002-01       Impact factor: 2.327

8.  An outbreak of mumps in Sweden, February-April 2004.

Authors:  B Sartorius; P Penttinen; J Nilsson; K Johansen; K Jönsson; M Arneborn; M Löfdahl; J Giesecke
Journal:  Euro Surveill       Date:  2005-09

9.  The epidemiology of mumps in the UK: a preliminary study of virus transmission, herd immunity and the potential impact of immunization.

Authors:  R M Anderson; J A Crombie; B T Grenfell
Journal:  Epidemiol Infect       Date:  1987-08       Impact factor: 2.451

10.  IMMUNITY IN MUMPS : I. EXPERIMENTS WITH MONKEYS (MACACUS MULATTA). THE DEVELOPMENT OF COMPLEMENT-FIXING ANTIBODY FOLLOWING INFECTION AND EXPERIMENTS ON IMMUNIZATION BY MEANS OF INACTIVATED VIRUS AND CONVALESCENT HUMAN SERUM.

Authors:  J F Enders; L W Kane; S Cohen; J H Levens
Journal:  J Exp Med       Date:  1945-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.